Duraibabu Prathyusha bought SGMO

February 25, 2025 · Form 4 insider transaction

Duraibabu Prathyusha bought 560,000 shares of Sangamo Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
560,000
Price
$0.00
Total value
N/A
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 25, 2025
Filing dateFebruary 26, 2025
Shares owned after560,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

One-quarter (1/4) of the shares subject to the option will vest and become exercisable on the first anniversary of the grant date, and the remainder of the shares will vest and become exercisable in 24 successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.

View the original Form 4 on SEC EDGAR